Drug Profile
SSS 24
Alternative Names: SSS-24Latest Information Update: 28 Oct 2019
Price :
$50
*
At a glance
- Originator 3SBio
- Class Small molecules
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Colorectal cancer
Most Recent Events
- 28 Oct 2019 No recent reports of development identified for phase-I development in Colorectal-cancer in China
- 19 Sep 2016 Phase-I clinical trials in Colorectal cancer in China, before September 2016 (3SBio pipeline, September 2016)
- 16 Sep 2016 Preclinical trials in Colorectal cancer in China, before September 2016 (3SBio pipeline, September 2016)